drugset / Trial / NCT01303445
Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers
RandomizedCrossoverOpen-label
Summary
The objective of the current study is to investigate if a drug-drug interaction occurs with the administration of omeprazole 80 mg q.d. at steady state on the pharmacokinetics of dipyridamole and the pharmacodynamics of ASA-induced platelet aggregation inhibition (components of Aggrenox®) when administered every 12 hours at steady state.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ASA | Unknown | — | — |
| Comparator | Dipyridamole | Other / unclassified | — | — |
| Subject | Omeprazole | Other / unclassified | 80 mg | — |
Indications
No indication recorded.